, , , , ,

Legs in Parkinson’s disease

24,50 

The legs in Parkinson’s disease have an altered function in mobility.
Moreover, under normal conditions, dopamine regulates voluntary
movements. Additionally, it allows smooth and coordinated execution.

tabla de tamaño y precio ilustraciones

plantilla

template

Legs in Parkinson’s disease. This image shows how the lower limbs exhibit involuntary movements and motor alterations characteristic of Parkinson’s disease. In this representation, the cerebral cortex, basal ganglia, substantia nigra, dopaminergic neurons, and motor system are identified. These structures enable movement control and coordination.

The legs in Parkinson’s disease have an altered function in mobility. Moreover, under normal conditions, dopamine regulates voluntary movements. Additionally, it allows smooth and coordinated execution. Furthermore, it ensures proper motor control.

On the other hand, in Parkinson’s disease, dopamine levels decrease. This loss occurs in the substantia nigra. Moreover, it affects communication within the basal ganglia. Additionally, this disrupts movement regulation in the limbs.

Transport of nerve signals occurs through neurotransmitters such as dopamine. For example, dopamine facilitates transmission between motor neurons. Moreover, when it decreases, motor signaling becomes irregular. Additionally, involuntary movements appear.

Key processes include altered motor circuits and dopamine deficiency. Moreover, resting tremor may appear in the legs. However, muscle rigidity is also observed. Additionally, slowness of movement during walking may occur.

Regulation depends on dopaminergic neuron activity. Moreover, genetic and environmental factors may influence it. Additionally, aging increases risk. Furthermore, progression is gradual.

As a result, coordination and balance are affected. Additionally, gait may become unstable. Moreover, the risk of falls increases.

Therefore, the legs in Parkinson’s disease reflect motor system dysfunction. In conclusion, dopamine deficiency affects mobility and patient stability.

No puedes copiar el contenido de esta página